Discovery of a NADPH oxidase inhibitor, (E)-3-cyclohexyl-5-(4-((2-hydroxyethyl)(methyl)amino)benzylidene)-1-methyl-2-thioxoimidazolidin-4-oneone, as a novel therapeutic for Parkinson's disease

  • Seunghwan Shim
  • , Da Un Jeong
  • , Hyemi Kim
  • , Chae Yun Kim
  • , Hyejun Park
  • , Yinglan Jin
  • , Kyung Min Kim
  • , Hwa Jeong Lee
  • , Dong Hwan Kim
  • , Yun Soo Bae
  • , Yongseok Choi

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Discovery of a NADPH oxidase inhibitor, (E)-3-cyclohexyl-5-(4-((2-hydroxyethyl)(methyl)amino)benzylidene)-1-methyl-2-thioxoimidazolidin-4-oneone, as a novel therapeutic for Parkinson's disease'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience